{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:52:15Z","timestamp":1793256735463,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2015-03219"],"award-info":[{"award-number":["2015-03219"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003748","name":"Swedish Society for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Swedish brain foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.neuropharm.2018.01.013","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T03:22:34Z","timestamp":1515727354000},"page":"343-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"PB","title":["GLP-1 signaling and alcohol-mediated behaviors; preclinical and clinical evidence"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2408-3165","authenticated-orcid":false,"given":"Elisabet","family":"Jerlhag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.01.013_bib1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/en.2011-1443","article-title":"GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake","volume":"153","author":"Alhadeff","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib2","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1046\/j.1471-4159.1996.66030920.x","article-title":"Expression of the glucagon-like peptide-1 receptor gene in rat brain","volume":"66","author":"Alvarez","year":"1996","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0014-2999(93)90434-J","article-title":"The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine","volume":"249","author":"Blomqvist","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-2999(97)01220-X","article-title":"Accumbal dopamine overflow after ethanol: localization of the antagonizing effect of mecamylamine","volume":"334","author":"Blomqvist","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/syn.10226","article-title":"Alcohol promotes dopamine release in the human nucleus accumbens","volume":"49","author":"Boileau","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.drugalcdep.2017.07.033","article-title":"Acute effects of intravenous cocaine administration on serum concentrations of ghrelin, amylin, glucagon-like peptide-1, insulin, leptin and peptide YY and relationships with cardiorespiratory and subjective responses","volume":"180","author":"Bouhlal","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1056\/NEJMoa1112082","article-title":"Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects","volume":"367","author":"Carlsson","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2018.01.013_bib8","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/ijo.2009.15","article-title":"Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery","volume":"33","author":"Cummings","year":"2009","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib9","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF02147990","article-title":"Localization of monoamines in the lower brain stem","volume":"20","author":"Dahlstrom","year":"1964","journal-title":"Experientia"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.biopsych.2012.01.035","article-title":"Gastric bypass surgery attenuates ethanol consumption in ethanol-preferring rats","volume":"72","author":"Davis","year":"2012","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib11","first-page":"952","article-title":"Degradation of glucagon-like peptide-1 by human plasma in\u00a0vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in\u00a0vivo","volume":"80","author":"Deacon","year":"1995","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1749-6632.1986.tb23629.x","article-title":"Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: studies with transcerebral dialysis in freely moving rats","volume":"473","author":"Di Chiara","year":"1986","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib13","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1523\/JNEUROSCI.6326-11.2012","article-title":"The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors","volume":"32","author":"Dickson","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib14","doi-asserted-by":"crossref","first-page":"14453","DOI":"10.1523\/JNEUROSCI.3262-11.2011","article-title":"Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake","volume":"31","author":"Dossat","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib15","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1097\/01.ALC.0000089959.66222.B8","article-title":"Dopamine activity in the nucleus accumbens during consummatory phases of oral ethanol self-administration","volume":"27","author":"Doyon","year":"2003","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0006-3223(00)01038-6","article-title":"Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria","volume":"49","author":"Drevets","year":"2001","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077284","article-title":"The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice","volume":"8","author":"Egecioglu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069010","article-title":"The glucagon-like Peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice","volume":"8","author":"Egecioglu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib19","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1369-1600.2010.00216.x","article-title":"Ghrelin increases intake of rewarding food in rodents","volume":"15","author":"Egecioglu","year":"2010","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.psyneuen.2012.11.009","article-title":"The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents","volume":"38","author":"Egecioglu","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF01244784","article-title":"Biochemical and behavioral evidence for an interaction between ethanol and calcium channel antagonists","volume":"74","author":"Engel","year":"1988","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/B978-0-444-63425-2.00009-X","article-title":"Alcohol: mechanisms along the mesolimbic dopamine system","volume":"211","author":"Engel","year":"2014","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s40263-014-0178-y","article-title":"Role of gut-brain hormones in the pathophysiology of alcoholism: implications for pharmacotherapy","volume":"28","author":"Engel","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0014-2999(98)00602-5","article-title":"Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine","volume":"358","author":"Ericson","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1369-1600.2010.00245.x","article-title":"Rising taurine and ethanol concentrations in nucleus accumbens interact to produce dopamine release after ethanol administration","volume":"16","author":"Ericson","year":"2011","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1124\/jpet.108.147058","article-title":"The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system","volume":"329","author":"Ericson","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-2999(03)01564-4","article-title":"Ethanol elevates accumbal dopamine levels via indirect activation of ventral tegmental nicotinic acetylcholine receptors","volume":"467","author":"Ericson","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.physbeh.2012.03.014","article-title":"Exendin-4 decreases amphetamine-induced locomotor activity","volume":"106","author":"Erreger","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.soard.2008.01.004","article-title":"Alcohol abuse and dependence before and after bariatric surgery: a review of the literature and report of a new data set","volume":"4","author":"Ertelt","year":"2008","journal-title":"Surg. Obes. Relat. Dis."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib30","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.ijo.0801627","article-title":"The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity","volume":"25","author":"Flint","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.physbeh.2017.03.019","article-title":"Central GLP-1 receptor activation modulates cocaine-evoked phasic dopamine signaling in the nucleus accumbens core","volume":"176","author":"Fortin","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yfrne.2009.10.003","article-title":"Appetite and reward","volume":"31","author":"Fulton","year":"2010","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib33","first-page":"185","article-title":"Neurobiology of alcohol dependence: focus on motivational mechanisms","volume":"31","author":"Gilpin","year":"2008","journal-title":"Alcohol Res. Health"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib34","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/mp.2012.141","article-title":"GLP-1 analog attenuates cocaine reward","volume":"18","author":"Graham","year":"2013","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049121","article-title":"Alcohol reward is increased after Roux-en-Y gastric bypass in dietary obese rats with differential effects following ghrelin antagonism","volume":"7","author":"Hajnal","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.neuropharm.2018.01.013_bib36","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/npp.2015.47","article-title":"Septal glucagon-like peptide 1 receptor expression determines suppression of cocaine-induced behavior","volume":"40","author":"Harasta","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib37","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1210\/en.2008-1479","article-title":"Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling","volume":"150","author":"Hayes","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/gbb.12344","article-title":"Reprogramming of mPFC transcriptome and function in alcohol dependence","volume":"16","author":"Heilig","year":"2017","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib39","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.pharmthera.2006.02.001","article-title":"Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms","volume":"111","author":"Heilig","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib40","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1046\/j.1460-9568.2000.00037.x","article-title":"Involvement of the medial septum in stress-induced relapse to heroin seeking in rats","volume":"12","author":"Highfield","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib41","doi-asserted-by":"crossref","first-page":"T31","DOI":"10.1530\/JOE-13-0221","article-title":"Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases","volume":"221","author":"Holscher","year":"2014","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1517\/14728214.9.1.155","article-title":"Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors","volume":"9","author":"Holst","year":"2004","journal-title":"Expet Opin. Emerg. Drugs"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2202-13-33","article-title":"Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis","volume":"13","author":"Hunter","year":"2012","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0022-3565(25)23929-5","article-title":"Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol","volume":"239","author":"Imperato","year":"1986","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib45","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1530-0277.2009.00924.x","article-title":"Effect of acute ethanol administration on the release of opioid peptides from the midbrain including the ventral tegmental area","volume":"33","author":"Jarjour","year":"2009","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib46","doi-asserted-by":"crossref","first-page":"11318","DOI":"10.1073\/pnas.0812809106","article-title":"Requirement of central ghrelin signaling for alcohol reward","volume":"106","author":"Jerlhag","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib47","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/alcalc\/agl049","article-title":"Role of the subunit composition of central nicotinic acetylcholine receptors for the stimulatory and dopamine-enhancing effects of ethanol","volume":"41","author":"Jerlhag","year":"2006","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib48","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib49","first-page":"2019","article-title":"Change in alcohol consumption following liraglutide initiation: a real life experience","author":"Kalra","year":"2011","journal-title":"71st Am. Diabetes Assoc. Conf."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib50","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.neuropharm.2011.12.022","article-title":"The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide","volume":"62","author":"Kanoski","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.ijo.0802206","article-title":"Entry of exendin-4 into brain is rapid but may be limited at high doses","volume":"27","author":"Kastin","year":"2003","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-6147(92)90060-J","article-title":"Drugs of abuse: anatomy, pharmacology and function of reward pathways","volume":"13","author":"Koob","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib53","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/B978-0-444-62619-6.00003-3","article-title":"Neurocircuitry of alcohol addiction: synthesis from animal models","volume":"125","author":"Koob","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib54","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib55","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0140-6736(87)91194-9","article-title":"Glucagon-like peptide-1 7-36: a physiological incretin in man","volume":"2","author":"Kreymann","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib56","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/alcalc\/agh180","article-title":"Voluntary ethanol intake increases extracellular acetylcholine levels in the ventral tegmental area in the rat","volume":"40","author":"Larsson","year":"2005","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.alcohol.2004.10.002","article-title":"Is an alpha-conotoxin MII-sensitive mechanism involved in the neurochemical, stimulatory, and rewarding effects of ethanol?","volume":"34","author":"Larsson","year":"2004","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0741-8329(02)00244-6","article-title":"Role of different nicotinic acetylcholine receptors in mediating behavioral and neurochemical effects of ethanol in mice","volume":"28","author":"Larsson","year":"2002","journal-title":"Alcohol"},{"issue":"9","key":"10.1016\/j.neuropharm.2018.01.013_bib59","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.biopsych.2014.03.019","article-title":"Intravenous ghrelin administration increases alcohol craving in alcohol-dependent heavy drinkers: a preliminary investigation","volume":"76","author":"Leggio","year":"2014","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib60","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0893-133X(02)00366-4","article-title":"Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET\/[11C]raclopride study in healthy men","volume":"27","author":"Leyton","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib61","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0163-7258(99)00040-6","article-title":"The contribution of electrophysiology to knowledge of the acute and chronic effects of ethanol","volume":"84","author":"Little","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib62","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1204622","article-title":"Linking context with reward: a functional circuit from hippocampal CA3 to ventral tegmental area","volume":"333","author":"Luo","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib63","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1360-0443.2012.04054.x","article-title":"Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?","volume":"108","author":"Maisel","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib64","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/jne.12086","article-title":"Glucagon-like peptide-1 receptor agonist administration suppresses both water and saline intake in rats","volume":"25","author":"McKay","year":"2013","journal-title":"J.\u00a0Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib65","first-page":"R23","article-title":"PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats","volume":"274","author":"McMahon","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib66","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5","article-title":"Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system","volume":"403","author":"Merchenthaler","year":"1999","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib67","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1037\/h0058775","article-title":"Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain","volume":"47","author":"Olds","year":"1954","journal-title":"J.\u00a0Comp. Physiol. Psychol."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib68","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1210\/endo-123-4-2009","article-title":"Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach","volume":"123","author":"Orskov","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib69","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.physbeh.2008.04.006","article-title":"Opioid reward 'liking' and 'wanting' in the nucleus accumbens","volume":"94","author":"Pecina","year":"2008","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib70","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/mp.2010.56","article-title":"A\u00a0genetic determinant of the striatal dopamine response to alcohol in men","volume":"16","author":"Ramchandani","year":"2011","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib71","doi-asserted-by":"crossref","first-page":"e809","DOI":"10.1038\/tp.2016.86","article-title":"Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels","volume":"6","author":"Reddy","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib72","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0140-6736(09)60746-7","article-title":"Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders","volume":"373","author":"Rehm","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119034","article-title":"Activation of the GLP-1 receptors in the nucleus of the solitary tract reduces food reward behavior and targets the mesolimbic system","volume":"10","author":"Richard","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib74","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0165-0173(93)90013-P","article-title":"The neural basis of drug craving: an incentive-sensitization theory of addiction","volume":"18","author":"Robinson","year":"1993","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib75","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0741-8329(85)90123-5","article-title":"Hyperventilation, anxiety, craving for alcohol: a subacute alcohol withdrawal syndrome","volume":"2","author":"Roelofs","year":"1985","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib76","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0165-6147(92)90065-E","article-title":"Neurobiology of alcohol abuse","volume":"13","author":"Samson","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib77","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1369-1600.2006.00012.x","article-title":"Behavioural assessment of drug reinforcement and addictive features in rodents: an overview","volume":"11","author":"Sanchis-Segura","year":"2006","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib78","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/npp.2015.362","article-title":"Glucagon-like Peptide-1 receptor activation in the ventral tegmental area decreases the reinforcing efficacy of cocaine","volume":"41","author":"Schmidt","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib79","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","volume":"124","author":"Secher","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib80","doi-asserted-by":"crossref","first-page":"214","DOI":"10.20882\/adicciones.708","article-title":"Opioid receptor antagonists in the treatment of alcoholism","volume":"27","author":"Serecigni","year":"2015","journal-title":"Adicciones"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib81","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejphar.2007.04.025","article-title":"Chronic progesterone treatment augments while dehydroepiandrosterone sulphate prevents tolerance to ethanol anxiolysis and withdrawal anxiety in rats","volume":"567","author":"Sharma","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.01.013_bib82","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s11011-014-9603-7","article-title":"Dipeptidyl-peptidase IV (DPP-IV) inhibitor delays tolerance to anxiolytic effect of ethanol and withdrawal-induced anxiety in rats","volume":"230","author":"Sharma","year":"2014","journal-title":"Metab. Brain Dis."},{"issue":"3","key":"10.1016\/j.neuropharm.2018.01.013_bib83","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s11011-014-9627-z","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonist prevents development of tolerance to anti-anxiety effect of ethanol and withdrawal-induced anxiety in rats","volume":"30","author":"Sharma","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061965","article-title":"Gut peptide GLP-1 and its analogue, Exendin-4, decrease alcohol intake and reward","volume":"8","author":"Shirazi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib85","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.physbeh.2016.04.013","article-title":"Central & peripheral glucagon-like peptide-1 receptor signaling differentially regulate addictive behaviors","volume":"161","author":"Sirohi","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib86","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1111\/acer.13199","article-title":"Effects of the GLP-1 agonist Exendin-4 on intravenous ethanol self-administration in mice","volume":"40","author":"Sorensen","year":"2016","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib87","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.physbeh.2015.06.013","article-title":"The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice","volume":"149","author":"Sorensen","year":"2015","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib88","first-page":"124","article-title":"Recent animal models of alcoholism","volume":"24","author":"Spanagel","year":"2000","journal-title":"Alcohol Res. Health"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib89","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1038\/tp.2015.68","article-title":"The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence","volume":"5","author":"Suchankova","year":"2015","journal-title":"Transl. Pational Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib90","first-page":"R848","article-title":"Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats","volume":"271","author":"Tang-Christensen","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib91","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pbb.2017.07.014","article-title":"The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice","volume":"160","author":"Thomsen","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.neuropharm.2018.01.013_bib92","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nn.4540","article-title":"GLP-1 acts on habenular avoidance circuits to control nicotine intake","volume":"20","author":"Tuesta","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib93","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.biopsych.2010.06.005","article-title":"Sex differences in striatal dopamine release in young adults after oral alcohol challenge: a positron emission tomography imaging study with [(1)(1)C]raclopride","volume":"68","author":"Urban","year":"2010","journal-title":"Biol. Psychiatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2018.01.013_bib94","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/adb.12295","article-title":"The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents","volume":"21","author":"Vall\u00f6f","year":"2016","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib95","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.2337\/db14-0849","article-title":"GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans","volume":"63","author":"van Bloemendaal","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2018.01.013_bib96","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.mp.4001507","article-title":"Dopamine in drug abuse and addiction: results from imaging studies and treatment implications","volume":"9","author":"Volkow","year":"2004","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib97","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1176\/ajp.154.1.50","article-title":"Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors","volume":"154","author":"Volkow","year":"1997","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib98","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrn.2017.130","article-title":"The dopamine motive system: implications for drug and food addiction","volume":"18","author":"Volkow","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib99","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/acer.12883","article-title":"Phosphatidylethanol is superior to carbohydrate-deficient transferrin and gamma-glutamyltransferase as an alcohol marker and is a reliable estimate of alcohol consumption level","volume":"39","author":"Walther","year":"2015","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib100","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0022-3565(25)39420-6","article-title":"Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants","volume":"267","author":"Weiss","year":"1993","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib101","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0163-7258(87)90108-2","article-title":"The role of reward pathways in the development of drug dependence","volume":"35","author":"Wise","year":"1987","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib102","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.ps.40.020189.001203","article-title":"Brain dopamine and reward","volume":"40","author":"Wise","year":"1989","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib103","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1530-0277.2007.00390.x","article-title":"Heterogeneous effects of alcohol on dopamine release in the striatum: a PET study","volume":"31","author":"Yoder","year":"2007","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2018.01.013_bib104","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/ijo.2009.65","article-title":"Appetite control and energy balance regulation in the modern world: reward-driven brain overrides repletion signals","volume":"33","author":"Zheng","year":"2009","journal-title":"Int. J. Obes."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818300133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818300133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:52:45Z","timestamp":1758437565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818300133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":104,"alternative-id":["S0028390818300133"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.01.013","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 signaling and alcohol-mediated behaviors; preclinical and clinical evidence","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}